Researchers to develop new prostate cancer therapy
Links shared publicly online about this topic.
- 78total visits
Researchers to develop new prostate cancer therapy
View full resource at news-medical.net
Tags: Hormone, Cancer, Chemotherapy, Prostate Cancer, Prostate, Men's Health, Radiation
Most Recently Shared on August 12, 2011 at 12:19 pm By:
Researchers to develop new prostate cancer therapy http://bit.ly/qcibmV
Also Shared By:
Researchers identify switches that can turn on or off genes associated with colorectal cancer
news-medical.net — “Two researchers at the Geisel School of Medicine at Dartmouth have helped to identify switches that can turn on or off genes associated with colorectal cancer. The finding offers clues about the development of colorectal cancer and could-potentially-provide targets for new therapies.” View full resource at news-medical.net
Most Recently Shared on May 4, 2012 at 6:13 am By:
Researchers identify switches that can turn on or off genes associated with colorectal cancer: Two researchers a... http://t.co/uXKSJPWm
Cancer Stem Cell Vaccine in Development Shows Antitumor Effect
aacr.org — “Stem cells had greater effect than differentiated tumor cells in eliciting antitumor immunity in vivo. Antibodies and T cells targeted cancer stem cells in laboratory models. Data could provide a rationale for a new type of immune therapy. PHILADELPHIA — Scientists may have discovered a new paradigm for immunotherapy against cancer by priming antibodies and T cells with cancer stem cells, according to a study published in Cancer Research, a journal of the American Association for Cancer Re” View full resource at aacr.org
Most Recently Shared on April 2, 2012 at 7:39 pm By:
Wendy Woodward MDPhD Physician, PhD, Doctor, Oncologist, and Radiation Oncologist
Cancer Stem Cell Vaccine in Development Shows Antitumor Effect: http://t.co/Ka40Ny2v via @AddThis #wwlab
Potential new therapy that kills cancer cells selectively
news-medical.net — “Researchers have made a drug that helps the immune system to break down cancerous tumors. It has worked on breast, bowel, prostate, ovarian, brain, bladder and liver cancers, while previous studies show it can also be used to fight some blood cancers. If given early, the drug could even be a cure, researchers say.” View full resource at news-medical.net
Most Recently Shared on March 28, 2012 at 10:15 pm By:
Potential new therapy that kills cancer cells selectively: Researchers have made a drug that helps the immune sy... http://t.co/FFPF2hPs
Brain Tumors
fhcrc.org — “Fred Hutchinson Cancer Research Center scientists are making promising discoveries to advance the treatment of brain tumors-including medulloblastoma. Our scientists are developing new ways to remove brain cancer with “tumor paint,” finding new uses for existing drugs and discovering new therapies for tumors including natural and stem cell-based treatments.” View full resource at fhcrc.org
Most Recently Shared on March 26, 2012 at 5:38 pm By:
Hutchinson Center Hospital and Research
Brain tumors: Learn more about our lifesaving research http://t.co/3dHUKh9j #braintumor #braincancer
Scientists identify new mechanism of prostate cancer cell metabolism
eurekalert.org — “Cancer cell metabolism may present a new target for therapy as scientists have uncovered a possible gene that leads to greater growth of prostate cancer cells.” View full resource at eurekalert.org
Most Recently Shared on March 22, 2012 at 3:03 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Scientists identify new mechanism of prostate cancer cell metabolism: ( American Association for Cancer Research... http://t.co/MEHK1v7R
Drug maker unblinds phase III study of advanced prostate Ca therapy - - ModernMedicine
modernmedicine.com — “Janssen Research & Development, LLC, recently has unblinded the phase III study of the androgen biosynthesis inhibitor abiraterone acetate (ZYTIGA) plus prednisone for the treatment of asymptomatic or mildly symptomatic patients with metastatic castration-resistant prostate cancer (CRPC) who have not received chemotherapy.” View full resource at modernmedicine.com
Most Recently Shared on March 20, 2012 at 8:55 am By:
Drug maker unblinds phase III study of advanced prostate Ca therapy: Janssen Research & Development, LLC, recent... http://t.co/tNN47rbu
Drug maker unblinds phase III study of advanced prostate Ca therapy - - UrologyTimes
urologytimes.modernmedicine.com — “Janssen Research & Development, LLC, recently has unblinded the phase III study of the androgen biosynthesis inhibitor abiraterone acetate (ZYTIGA) plus prednisone for the treatment of asymptomatic or mildly symptomatic patients with metastatic castration-resistant prostate cancer (CRPC) who have not received chemotherapy.” View full resource at urologytimes.modernmedicine.com
Most Recently Shared on March 20, 2012 at 4:17 am By:
Drug maker unblinds phase III study of advanced prostate Ca therapy: Janssen Research & Development, LLC, recent... http://t.co/ehOaPbGc
Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers
onclive.com — “Recognition of breast cancer subtypes and research into their underlying biologies is driving the development of new therapies.” View full resource at onclive.com
Most Recently Shared on March 16, 2012 at 4:02 pm By:
Emerging Therapies for HER2-Positive and Triple-Negative Breast Cancers http://t.co/2snjBVs6 #MBCC12
Estrogen-only form of menopausal hormone therapy may protect against breast cancer
news-medical.net — “Rowan T. Chlebowski, M.D., Ph.D., an LA BioMed investigator whose research activities have focused on breast cancer therapy and prevention, and chronic diseases impacting women's health, is co-author of a study that indicates that women who use the estrogen-only form of menopausal hormone therapy appear less likely to develop breast cancer in the longer term, according to new research which was recently published The Lancet Oncology.” View full resource at news-medical.net
Most Recently Shared on March 12, 2012 at 8:18 am By:
Estrogen-only form of menopausal hormone therapy may protect against breast cancer: Rowan T. Chlebowski, M.D., P... http://t.co/BZ5LuVYT
Circumcision tied to lower prostate cancer risk - Yahoo! News
news.yahoo.com — “From Yahoo! News: NEW YORK (Reuters Health) - Circumcised men may have a slightly lower risk of developing prostate cancer than those who still have their foreskin, according to a new study. The World Health Organization already recommends the controversial procedure based on research showing it lowers heterosexual men's risk of contracting HIV, the virus that causes AIDS. Last year, scientists also reported that wives and girlfriends of circumcised men had lower rates of infection with human pa” View full resource at news.yahoo.com
Most Recently Shared on March 12, 2012 at 6:27 am By:
Circumcision tied to lower prostate cancer risk: NEW YORK (Reuters Health) - Circumcised men may have a slightly... http://t.co/hjIGiSRt
Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded
medicalnewstoday.com — “A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednis” View full resource at medicalnewstoday.com
Most Recently Shared on March 10, 2012 at 4:05 pm By:
Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded http://t.co/H8i9JKFU #healthnews
Development Of New Universal Platform For Cancer Immunotherapy
medicalnewstoday.com — “Researchers from the Perelman School of Medicine at the University of Pennsylvania report this month in Cancer Research a universal approach to personalized cancer therapy based on T cells.” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2012 at 9:07 am By:
Development Of New Universal Platform For Cancer Immunotherapy http://t.co/v1fgEdzO #lymphology
Research and Markets: Focal Therapy in Prostate Cancer - Yahoo! Finance
finance.yahoo.com — “From Yahoo! Finance: Research and Markets has announced the addition of John Wiley and Sons Ltd's new book "Focal Therapy in Prost” View full resource at finance.yahoo.com
Most Recently Shared on March 6, 2012 at 3:12 pm By:
Research and Markets: Focal Therapy in Prostate Cancer: Research and Markets has announced the addition of John ... http://t.co/4C973MuJ
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
hindawi.com — “Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has given us a better understanding on the mechanisms of CRPC. This great investment has turned into a more rational approach to the development of new drugs. Some of the new treatments are already availabl” View full resource at hindawi.com
Most Recently Shared on March 6, 2012 at 6:38 am By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment: Patients with castration-resistant pro... http://t.co/clU67W43
New Prostate Cancer Drug Target Identified
medicalnewstoday.com — “Research led by Wanguo Liu, PhD, Associate Professor of Genetics at LSU Health Sciences Center New Orleans, has identified a new protein critical to the development and growth of prostate cancer.” View full resource at medicalnewstoday.com
Most Recently Shared on February 7, 2012 at 9:05 am By:
New Prostate Cancer Drug Target Identified http://t.co/grL48B0p #prostate
Advertisement
News-Medical.Net
@prostatecancers
Prostate Cancer: Potential new therapy that kills cancer cells selectively: Researchers have made a drug that he... http://t.co/WLXG2ez2
1 year ago...